MARKET

GRAL

GRAL

Grail Inc
NASDAQ
100.07
+6.01
+6.39%
After Hours: 99.25 -0.82 -0.82% 19:59 02/06 EST
OPEN
98.30
PREV CLOSE
94.06
HIGH
101.01
LOW
96.75
VOLUME
724.08K
TURNOVER
--
52 WEEK HIGH
118.84
52 WEEK LOW
20.44
MARKET CAP
3.90B
P/E (TTM)
-8.6045
1D
5D
1M
3M
1Y
5Y
1D
Hims & Hers Is Offering a New Cancer Test. It May Not Be Ready for Prime Time.
Barron‘s · 1d ago
What GRAIL (GRAL)'s FDA PMA Submission for Galleri Test Means For Shareholders
Simply Wall St · 1d ago
A Look At GRAIL (GRAL) Valuation As FDA PMA Submission For Galleri Test Reaches Final Stage
Simply Wall St · 2d ago
Hims & Hers rolls out GRAIL’s multi cancer screening test
Seeking Alpha · 3d ago
Hims & Hers Health kooperiert mit GRAIL für Multi-Krebs-Früherkennungstest
Reuters · 3d ago
Hims & Hers Teams Up With GRAIL to Offer Multi-Cancer Early Detection Test
Reuters · 3d ago
Weekly Report: what happened at GRAL last week (0126-0130)?
Weekly Report · 5d ago
GRAIL (GRAL) Is Down 13.0% After Final PMA Module Filing for Galleri Multi-Cancer Test
Simply Wall St · 01/30 17:25
More
About GRAL
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.